Hospital in County Westmeath adds ultrasound system to elevate prostate cancer diagnostics
Charter Medical Private Hospital in Mullingar, Ireland, has introduced the Esaote MyLab E80 ultrasound system with UroFusion technology to its urology service. The platform will be used by consultant urologist Mr Asadullah Aslam to perform targeted prostate biopsies.
The MyLab E80 is designed to deliver exceptional image quality, advanced processing and a user-friendly workflow. Combined with UroFusion technology, it allows rapid MRI ultrasound fusion for targeted prostate biopsies, improving lesion localisation and supporting more precise sampling of suspicious areas.
“The exceptional image quality of the Esaote MyLab E80 will benefit the service offered to our patients greatly,” said Mr Aslam. “It allows us to visualise prostate pathology with far greater clarity and confidence. When combined with UroFusion for MRI-ultrasound fusion biopsy, this technology will help us offer a level of diagnostic excellence that our patients deserve and will significantly raise the standard of our urology service at Charter Medical.”
The E80 with UroFusion supports the goal of accurate and timely diagnosis of prostate cancer by enabling high resolution imaging for improved visualisation of prostate anatomy and suspicious lesions; fusion of MRI and real-time ultrasound to guide targeted biopsies; and optimised workflow and ergonomics.
“We are delighted that Charter Medical Private Hospital and Mr Aslam have chosen the MyLab E80 with UroFusion for their urology service,” said an Esaote representative. “Our aim is to empower clinicians with exceptional image quality and smart tools that support confident, evidence-based decisions. Seeing this technology integrated into such a high quality service is a strong endorsement of that mission.”
Picture: Esaote UK and Ireland applications and clinical education business development manager Emma Burgess with Charter Medical Private Hospital consultant urologist Mr Asadullah Aslam.
Read this report on the front page of the February 2026 issue of RAD Magazine.
